Clinical Trial Update: Open Label, Controlled, Post Marketing, Registry Study of Ribociclib (Ribo) Treatment Adherence and Patient Reported Outcomes in Participants Using ReX Technology Platform [NA]

View source ↗

Summary

Open-label registry study evaluating ribociclib treatment adherence and patient-reported outcomes using the ReX technology platform; the study is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Ribociclib (ribociclib)

Snippet

Sponsor: Dosentrx Ltd. | Conditions: Any Solid Oral Medication | NA | Status: RECRUITING